Research Fellow, Centre for Public Health
Application closing date 16/10/2019
Salary £33,797 per annum
Job category/type Research
Queen's University Belfast is one of the prestigious Russell Group of UK research-intensive universities in the UK and Ireland, combining excellence in research and education with a student centred ethos, for our 24,000 students and 4,200 staff, funded through an annual turnover of some GBP 300m. As a driver of innovation and talent, based on excellence and global strategic partnerships, we offer generous employment terms and underpinned by excellent lifestyle benefits including opportunities for family friendly working and support for wellbeing.
Our five core values - Integrity, Connected, Ambition, Respect, Excellence - are shared by our staff and students, representing the expectations we have for ourselves and each other, guiding our day-to-day decisions and the way we behave as individuals in an international organisation.
The Centre for Public Health (CPH) sits within the School of Medicine, Dentistry and Biomedical Sciences (MDBS) at Queen's University Belfast. The Centre aims to advance the health of the public at a regional, national and international level, by increasing knowledge and influencing clinical and public health practice and policy.
We are recruiting for a Research Fellow who will will work on the NEPHSTROM study. This is a phase 1-2 trial to establish the safety and tolerability of a single intravenous infusion of stem cells in the treatment of patients with type II diabetes and progressive diabetic kidney disease. As part of the study an exploratory economic evaluation of the intervention will be conducted under the direction of Professor Ciaran O'Neill.
The Research Fellow will undertake the development and analysis of a Marokovian model of the infusion of stem cells compared with a placebo within a cost-utility analysis. The model will be populated with data collected alongside the clinical trial, augmented as necessary with data from the literature. The study will examine costs, effects and provide an indicative cost-utility analysis of the intervention against a placebo provided in conjunction with usual care. The trial will be conducted in three European countries: Ireland, Italy and the UK.
This post is available full time for until 31 October 2020.
The successful candidate must have:
- A PhD in economics or cognate subject or having given notice to submit PhD within 3 months.
- At least three years relevant experience
- Good evidence of extensive experience in applied health economics research.
- Experience in publishing in medical and health services, health policy and/or health economics journals.
- Experience of using data analysis packages such as TreeAge, STATA or R.